TL;DR: Trump’s surprise hemp ban doesn’t just wipe out a massive part of the hemp-derived market; it may also create the legal framework for a broader federal crackdown on cannabis. With the Heritage Foundation and Project 2025 arguing for centralized FDA authority and tougher interstate enforcement, the hemp ban could mark the first real test of a new, more aggressive national drug policy that threatens both hemp and state-legal cannabis operators.
In November 2025, Donald Trump, once celebrated as the president who legalized hemp, signed the most far-reaching hemp prohibition in modern U.S. history. The provision was buried deep inside the bill that reopened the federal government. With almost no debate and virtually no public awareness, Congress rewrote the legal definition of hemp, capping every hemp-derived product at 0.4 milligrams of total THC per container and banning all cannabinoids produced through chemical conversion. Beverages, gummies, vapes, tinctures, even intermediate extracts used in manufacturing will be pushed back into Schedule I on November 13, 2026.
Seven years after the 2018 Farm Bill created a national hemp economy, the federal government has now swung the pendulum in the opposite direction. Let me pose the uncomfortable question: Is this prohibition a justified correction to cannabis policy—forcing thousands of hemp operators to finally comply with the strict regulatory framework that cannabis companies have endured for years? Or is there a deeper, more dangerous trajectory emerging?
If you are a small cannabis operator celebrating the collapse of the hemp economy, beware: this may be only the first move in a broader conservative counteroffensive.
An Ideological Weather Front Moves In
Look closely at the Heritage Foundation’s cannabis philosophy. The Heritage Foundation is a major conservative think tank that has shaped Republican policy for decades, and it is, by far, one of the most articulate and influential conservative institutions in American politics. For more than ten years, it has been constructing an intellectual and legal case for returning cannabis to full federal prohibition. Paul J. Larkin Jr., one of its most prolific legal ideologues, recently published an Op Ed titled “Rescheduling Cannabis Downwards Would Be a Huge Mistake.”
Also read: Narco-Terror or Political Theater? Inside the U.S. War on Boats off Venezuela and Colombia
Larkin argues that the FDA has never approved botanical cannabis as a drug that meets the standards of safety, efficacy, and uniformity required by the Food, Drug, and Cosmetic Act—only “the synthesis of compounds found in the plant.” You can already sense where this is going.
Because of this reasoning, Larkin insists that even if cannabis is rescheduled, interstate distribution will remain illegal, and no amount of state regulation can substitute for federal FDA approval. In his framework, the plant itself never justifies any real relaxation of federal control. The same logic applies to hemp extracts, regardless of whether they come from a “legal” crop.
This ideological posture aligns neatly with the underlying spirit of Project 2025, the MAGA-aligned blueprint for reorganizing the federal government.
Might a Centralized Government Enforce Anti-Cannabis Laws After the Hemp Ban?
The political philosophy behind Project 2025 includes recentralizing executive power, consolidating enforcement, and curbing agency independence. Together, those pillars create precisely the conditions under which federal authorities could intervene in state cannabis markets if they choose to.
Larkin himself repeatedly emphasizes that only a single federal authority–the FDA–can determine whether a substance is safe. Under a Project 2025–style administration, Schedule III could be deployed not as a step toward normalization but as a pretext for demanding FDA approval and policing dispensaries that, by definition, cannot obtain such approval. This concern is not new, and it was recently raised by cannabis activists in a High Times article on the matter.
The Justice Department chapter of Mandate for Leadership: The Conservative Promise — the central policy document of Project 2025 — even directs the federal government to “rigorously prosecute as much interstate drug activity as possible, including simple possession of distributable quantities.”
That single line helps illuminate the ideological atmosphere surrounding the hemp ban.
Also read: It’s a Trap! Why Schedule III Could Be Worse Than Standing Still on Cannabis Reform
The political process behind the ban was stunning for both its speed and opacity. The language was inserted into a must-pass appropriations bill without hearings, testimony, or debate, redefining hemp so broadly that nearly all consumer products become illegal marijuana.
Mitch McConnell, the senator who once shepherded hemp legalization, admitted publicly that the Farm Bill never intended to authorize a national market of THC-infused beverages, and quietly supported the new restrictions. Rand Paul objected, but his amendment to remove the prohibition failed.
How the Hemp Ban Could Harm Cannabis Instead of Saving It
It may be tempting for parts of the cannabis industry to assume that the hemp ban will finally “level the playing field.” This view might be shortsighted because of looming political risks in the precedent of banning an entire sector virtually overnight. While MAGA rhetoric criticizes Schedule III, a future administration could easily use it to exert more, not less, control over the cannabis supply chain.
Under the Food, Drug, and Cosmetic Act, selling cannabis across state lines, or even within a single state, still qualifies as distributing an unapproved drug. And while rescheduling offers tax relief, it also provides new federal leverage points.
Project 2025 makes a forceful case for concentrating power within the executive branch, and Schedule III provides extra legal hooks that could be used under a more centralized enforcement model.
This is precisely how Josh Kesselman, creator of RAW® brand rolling papers and co-owner of High Times, interprets the current moment: “First they ban hemp, and the next part will be to ban cannabis, which is already illegal (at the federal level), but if it becomes S3, a drug, they can use federal agencies to force out dispensaries for selling a medical drug without a license.”
In his reading, once the hemp-derived THC sector is eliminated, Schedule III becomes the bridge to demand pharmaceutical-grade approval, creating a cannabis economy based on compounds rather than flower.
The Ban on Marijuana Seeds
One of the least discussed yet most far-reaching parts of the new hemp prohibition is its effect on cannabis seeds. Under the 2018 Farm Bill, all cannabis seeds were legal hemp because they contain almost no delta-9 THC. The law defined hemp as “any part of the plant, including the seeds thereof… with not more than 0.3% delta-9 THC,” and the DEA confirmed in 2022 that this applied even to seeds from high-THC strains. This created a national market for cannabis genetics where breeders in California could legally ship seeds to New York, Florida, or Michigan.
Section 781 shuts that system down.
Also read: This Single Decision Keeps $10 Billion in Weed Money Out of America’s Economy—Every Year
The revised definition now states that hemp “does not include… any viable seeds from a Cannabis sativa L. plant that exceeds a total tetrahydrocannabinols concentration of 0.3%.” Meaning, seeds are no longer judged by their chemical content, but by the THC potential of the plant they grow into. If the mature plant would exceed 0.3% total THC, its seeds are federally classified as marijuana even if the seeds themselves contain virtually no THC.
This change makes interstate seed commerce legally impossible.
Moving a new strain’s seeds across state lines is now federal marijuana trafficking. National genetics companies lose their legal pathway, and growers become confined to in-state breeding. In a single sentence, Congress eliminated the nationwide exchange of cannabis genetics that has powered innovation for years.
Don’t Sleep While Your Bed Is Burning
The final market would inevitably favor Big Pharma and perhaps some of the largest multistate cannabis corporations.
Of course, many things would need to happen in between. Federal resources are limited and local governments retain political leverage, so an enforcement strategy in this direction might be constrained by state power.
Lobbyists involved in the hemp negotiations describe the process as a chaotic mix of late-night maneuvering, McConnell’s influence, and regulatory frustration.
In that view, the hemp ban emerged from political drift, not strategic design.
But intentions are one thing; consequences are another.
Under a Heritage-aligned administration, the FDA could justify enforcement against state markets by arguing that dispensaries may not distribute a prescription-only Schedule III substance without approval.
Moreover, states such as Minnesota and Texas are already adopting their own hemp definitions, setting the stage for future conflict.
Also read: Everyone’s Cashing In on Legal Weed—Except America
What we can see now is a longstanding ideological campaign from Heritage, a growing conservative appetite for centralizing federal authority, and a set of legal tools that could make enforcement easier than in years past. The hemp ban has already demonstrated Congress’s capacity to recriminalize entire sectors of the hemp economy overnight. Schedule III introduces regulatory liabilities that never existed under Schedule I. And the political movement likely to influence federal power in 2025 has openly signaled its hostility to cannabis markets.
This is the terrain in which the industry now operates. A crackdown does not require a master plan. It only requires ideology, agency, and opportunity.
So I would hold off on the champagne. The plant has always been one and the same. It was nothing more than an accidental legal definition that divided the cannabis economy into a tightly regulated cannabis market and an irresponsibly liberalized hemp-derived market. Whether by design or drift, the danger is the same.
Unless the cannabis community confronts the implications of this new legal architecture, those who built this industry may once again find themselves under a federal system that treats the plant as contraband and reserves the marketplace for the few actors powerful enough to withstand that federal system.In the political economy of cannabis, the fundamental question remains unchanged: Who is allowed to produce and sell cannabis? And behind that question lies the oldest conflict in political life: the fight between the will of the few and the needs of the many.
Photo by Ashes Sitoula on Unsplash
